DE2348334C2 - Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs - Google Patents

Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs

Info

Publication number
DE2348334C2
DE2348334C2 DE2348334A DE2348334A DE2348334C2 DE 2348334 C2 DE2348334 C2 DE 2348334C2 DE 2348334 A DE2348334 A DE 2348334A DE 2348334 A DE2348334 A DE 2348334A DE 2348334 C2 DE2348334 C2 DE 2348334C2
Authority
DE
Germany
Prior art keywords
chloro
mvg
preparation
active ingredient
bet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2348334A
Other languages
German (de)
English (en)
Other versions
DE2348334A1 (de
Inventor
Günter Dr.med. 6800 Mannheim Betzien
Helmut Dr.Rer.Nat. 6900 Heidelberg Heinemann
Werner Dr.Rer.Nat. 6832 Hockenheim Rothe
Felix Helmut Dr.Rer.Nat. Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE2348334A priority Critical patent/DE2348334C2/de
Priority to NLAANVRAGE7412393,A priority patent/NL174222C/xx
Priority to GB4104374A priority patent/GB1420907A/en
Priority to FI2755/74A priority patent/FI58068C/fi
Priority to US05/508,001 priority patent/US3979520A/en
Priority to ZA00745967A priority patent/ZA745967B/xx
Priority to CA209,965A priority patent/CA1029661A/en
Priority to AT762374A priority patent/AT330954B/de
Priority to BE148814A priority patent/BE820254A/xx
Priority to AU73653/74A priority patent/AU480904B2/en
Priority to FR7432255A priority patent/FR2244455B1/fr
Priority to SE7412044A priority patent/SE402210B/xx
Priority to JP11095974A priority patent/JPS5632967B2/ja
Publication of DE2348334A1 publication Critical patent/DE2348334A1/de
Priority to US05/688,435 priority patent/US4060634A/en
Application granted granted Critical
Publication of DE2348334C2 publication Critical patent/DE2348334C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2348334A 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs Expired DE2348334C2 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE2348334A DE2348334C2 (de) 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
NLAANVRAGE7412393,A NL174222C (nl) 1973-09-26 1974-09-19 Werkwijze ter bereiding van een sterk werkzame, snel resorbeerbare vorm van n-4-(2-(5-chloor-2-methoxybenzamido)ethyl)fenylsulfonyl-n'- cyclohexylureum, en voor de bereiding van een farmaceutisch preparaat dat deze bevat.
FI2755/74A FI58068C (fi) 1973-09-26 1974-09-20 Foerfarande foer framstaellning av en hoegverksam snabbt resorberbar beredningsform av n-4-(2-(5-klor-2-metoxibensamido)-etyl)-fenyl-sulfonyl-n'-cyklohexylkarbamid
US05/508,001 US3979520A (en) 1973-09-26 1974-09-20 Preparation of rapidly resorbable glibenclamide
ZA00745967A ZA745967B (en) 1973-09-26 1974-09-20 New form of n-4-<2-(5-chloro-2-methoxy-benzamido)-ethyl>-phenyl-sulphonyl-n1-cyclohexylurea
GB4104374A GB1420907A (en) 1973-09-26 1974-09-20 N-4-2-5-chloro-2-methoxybenzamido-ethyl-phenyl-sulphonyl-n,- cyclohexylurea in particulate form
CA209,965A CA1029661A (en) 1973-09-26 1974-09-23 Form of n-4-(2-(5-chloro-2-methoxy-benzamido)-ethyl)-phenylsulphonyl-n'-cyclohexylurea
AT762374A AT330954B (de) 1973-09-26 1974-09-23 Verfahren zur herstellung eines pharmazeutischen praparates
BE148814A BE820254A (fr) 1973-09-26 1974-09-24 Nouvelle forme d'administration de la n-4-(2-(5-chloro-2-methoxybenzamido)- ethyl)-phenyl-sulfonyl-n'-cyclohexyl-uree
AU73653/74A AU480904B2 (en) 1973-09-26 1974-09-24 New form n-4-[2-(5-chloro-2-methoxybenzamido)-ethyl]-phenyl-sulphony l-n-cyclohexylurea
FR7432255A FR2244455B1 (show.php) 1973-09-26 1974-09-25
SE7412044A SE402210B (sv) 1973-09-26 1974-09-25 Forfarande for framstellning av en hogverksam, snabbt resorberbar beredningsform av n-4-(2-(5-klor-2-metoxibensamido)-etyl)-fenylsulfonyl-n'-cyklohexylkarbamid
JP11095974A JPS5632967B2 (show.php) 1973-09-26 1974-09-26
US05/688,435 US4060634A (en) 1973-09-26 1976-05-20 Rapidly resorbable glibenclamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2348334A DE2348334C2 (de) 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs

Publications (2)

Publication Number Publication Date
DE2348334A1 DE2348334A1 (de) 1975-03-27
DE2348334C2 true DE2348334C2 (de) 1982-11-11

Family

ID=5893666

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2348334A Expired DE2348334C2 (de) 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs

Country Status (12)

Country Link
US (1) US3979520A (show.php)
JP (1) JPS5632967B2 (show.php)
AT (1) AT330954B (show.php)
BE (1) BE820254A (show.php)
CA (1) CA1029661A (show.php)
DE (1) DE2348334C2 (show.php)
FI (1) FI58068C (show.php)
FR (1) FR2244455B1 (show.php)
GB (1) GB1420907A (show.php)
NL (1) NL174222C (show.php)
SE (1) SE402210B (show.php)
ZA (1) ZA745967B (show.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3326167A1 (de) * 1983-07-20 1985-02-21 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung
CA1282405C (en) * 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
CN1090935C (zh) * 1995-02-28 2002-09-18 阿温蒂斯药物公司 哌啶子基烷醇化合物的药物组合物
ID22891A (id) * 1997-08-26 1999-12-16 Hoechst Marion Roussel Inc Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
EP0974356B1 (en) * 1998-07-15 2003-09-24 Merck Sante Tablets comprising a combination of metformin and glibenclamide
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) * 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
WO2006109175A2 (en) * 2005-04-11 2006-10-19 Aurobindo Pharma Limited Solid dosage form of an antidiabetic drug
CN104098489A (zh) * 2014-07-10 2014-10-15 沈阳药科大学 一种微粉化格列本脲及其组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB694280A (en) * 1950-09-19 1953-07-15 Merck & Co Inc A stable, non-caking suspension of cortisone acetate in an isotonic aqueous vehicle and the process of preparing said composition
US3008873A (en) * 1957-02-07 1961-11-14 Merck & Co Inc Controlled particle size of 4, 4-dinitrocarbanilide
GB1030395A (en) * 1962-12-26 1966-05-25 Upjohn Co Hypoglycemic sulphonyl urea medicaments
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
DE2017495A1 (en) * 1970-04-11 1971-11-04 Merck Patent Gmbh, 6100 Darmstadt Sulphonamides embedded in galactomannans
JPS4932056B1 (show.php) * 1970-12-22 1974-08-27

Also Published As

Publication number Publication date
FI275574A7 (show.php) 1975-03-27
NL174222B (nl) 1983-12-16
JPS5632967B2 (show.php) 1981-07-31
CA1029661A (en) 1978-04-18
ZA745967B (en) 1975-11-26
NL174222C (nl) 1984-05-16
FR2244455A1 (show.php) 1975-04-18
AT330954B (de) 1976-07-26
US3979520A (en) 1976-09-07
FR2244455B1 (show.php) 1978-07-21
SE402210B (sv) 1978-06-26
AU7365374A (en) 1976-04-01
JPS5058216A (show.php) 1975-05-21
FI58068C (fi) 1980-12-10
SE7412044L (show.php) 1975-03-27
GB1420907A (en) 1976-01-14
FI58068B (fi) 1980-08-29
BE820254A (fr) 1975-03-24
ATA762374A (de) 1975-10-15
NL7412393A (nl) 1975-04-01
DE2348334A1 (de) 1975-03-27

Similar Documents

Publication Publication Date Title
DE2348334C2 (de) Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N&#39;-cyclohexylharnstoffs
EP0128482B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
EP1059920B1 (de) Verwendung von alkylhydrogenfumaraten zur behandlung von psoriasis, psoriatischer arthritis, neurodermitis und enteritis regionalis crohn
DE60120916T2 (de) Glyburid-zusammensetzung
EP0128483B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
DE3318649A1 (de) Zweiphasenformulierung
DE1106454B (de) UEberzugsmittel fuer Arzneistoffe
CH622947A5 (en) Process for the production of a pharmaceutical composition which is in solid form and contains bismuth
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE3438455A1 (de) L-lysin- und l-histidinpyruvat
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
EP0722719B1 (de) Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen
DE19710054A1 (de) Pharmazeutische Zubereitung
DE69322411T2 (de) Arzneizusammensetzungen enthaltend tandospiron oder seine analoge
EP0445158B1 (de) Zubereitungen des oxipurinols und/oder seiner alkali- oder erdalkalisalze
DE2403122C2 (show.php)
DE69807745T2 (de) Monoargininylsalz der (e)-3-[1-n-butyl-5-[(2-(2-carboxyphenyl)methoxy-4-chlorphenyl]-1h-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-en carbonsäure
EP0043548B1 (de) Salz aus Furosemid oder Piretanid als Säurekomponente und Penbutolol als Basenkomponente sowie Arzneimittel, das beide Komponenten enthält
DE69524226T2 (de) Verfahren zum herstellen von fusidinsäuretabletten
DE2428639A1 (de) Therapeutische mittel
DE3636209A1 (de) Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE2132923C3 (de) Arzneimittel zur oralen Therapie der Herzinsuffizienz
DE2157201B2 (de) Verbesserte feste orale Applikationsform von Raubasin
EP0201571B1 (de) Pharmazeutische zusammensetzung, ihre herstellung und verwendung
DE3333008C2 (show.php)

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination
8363 Opposition against the patent
8363 Opposition against the patent